Naoei Yoshitani
Papers
1
Total Citations
64
H-Index
1
About
Dr. Naoei Yoshitani has pioneered innovative approaches at the intersection of structural biology and drug discovery, with a primary focus on developing strategies to identify small-molecule ligands for functionally uncharacterized proteins. Their most impactful contribution is a structure-based methodology that integrates *in silico* screening with surface plasmon resonance (SPR) measurements, enabling the rational discovery of small binding compounds for proteins of unknown function—a critical challenge in the postgenomic era. This landmark work, published in 2005 and cited over 60 times, established a powerful pipeline for functional annotation and early-stage drug development. By combining computational predictions with direct biophysical validation, Yoshitani’s approach has provided a template for researchers seeking to bridge the gap between structural genomics and chemical biology. Their work has been instrumental in demonstrating how targeted ligand discovery can unlock the biological roles of orphan proteins, accelerating both basic research and therapeutic target identification. Yoshitani’s contributions continue to influence the design of integrated screening platforms, making them a key figure in the advancement of structure-guided chemical biology.
Research Focus
Key Achievements
Top Papers
- 1